MARIO
DELGADO MORA
Investigador hasta 2008
Elena
Gonzalez-Rey
Publicaciones en las que colabora con Elena Gonzalez-Rey (51)
2019
2009
-
Adipose-Derived Mesenchymal Stem Cells Alleviate Experimental Colitis by Inhibiting Inflammatory and Autoimmune Responses
Gastroenterology, Vol. 136, Núm. 3, pp. 978-989
-
Human adult stem cells derived from adipose tissue protect against experimental colitis and sepsis
Gut, Vol. 58, Núm. 7, pp. 929-939
-
Neuropeptides kill African trypanosomes by targeting intracellular compartments and inducing autophagic-like cell death
Cell Death and Differentiation, Vol. 16, Núm. 3, pp. 406-416
-
Treatment of experimental arthritis by inducing immune tolerance with human adipose-derived mesenchymal stem cells
Arthritis and Rheumatism, Vol. 60, Núm. 4, pp. 1006-1019
2008
-
Emergence of cortistatin as a new immunomodulatory factor with therapeutic potential in immune disorders
Molecular and Cellular Endocrinology, Vol. 286, Núm. 1-2, pp. 135-140
-
Genetic association of vasoactive intestinal peptide receptor with rheumatoid arthritis: Altered expression and signal in immune cells
Arthritis and Rheumatism, Vol. 58, Núm. 4, pp. 1010-1019
-
Ghrelin protects against experimental sepsis by inhibiting high-mobility group box 1 release and by killing bacteria
Journal of Immunology, Vol. 180, Núm. 12, pp. 8369-8377
-
In vivo delivery of lentiviral vectors expressing vasoactive intestinal peptide complementary DNA as gene therapy for collagen-induced arthritis
Arthritis and Rheumatism, Vol. 58, Núm. 4, pp. 1026-1037
-
Vasoactive intestinal peptide inhibits cycloxygenase-2 expression in activated macrophages, microglia, and dendritic cells
Brain, Behavior, and Immunity, Vol. 22, Núm. 1, pp. 35-41
-
Vasoactive intestinal peptide protects against β-amyloid-induced neurodegeneration by inhibiting microglia activation at multiple levels
GLIA, Vol. 56, Núm. 10, pp. 1091-1103
2007
-
Adrenomedullin protects from experimental arthritis by down-regulating inflammation and Th1 response and inducing regulatory T cells
American Journal of Pathology, Vol. 170, Núm. 1, pp. 263-271
-
Anti-inflammatory neuropeptide receptors: new therapeutic targets for immune disorders?
Trends in Pharmacological Sciences, Vol. 28, Núm. 9, pp. 482-491
-
Emerging roles of vasoactive intestinal peptide: A new approach for autoimmune therapy
Annals of the Rheumatic Diseases
-
Regulation of immune tolerance by anti-inflammatory neuropeptides
Nature Reviews Immunology, Vol. 7, Núm. 1, pp. 52-63
-
Therapeutic effect of a poly(ADP-ribose) polymerase-1 inhibitor on experimental arthritis by downregulating inflammation and Th1 response
PLoS ONE, Vol. 2, Núm. 10
-
Therapeutic effect of cortistatin on experimental arthritis by downregulating inflammatory and Th1 responses
Annals of the Rheumatic Diseases, Vol. 66, Núm. 5, pp. 582-588
-
Therapeutic effect of urocortin on collagen-induced arthritis by down-regulation of inflammatory and Th1 responses and induction of regulatory T cells
Arthritis and Rheumatism, Vol. 56, Núm. 2, pp. 531-543
-
Therapeutical approaches of vasoactive intestinal peptide as a pleiotropic immunomodulator
Current Pharmaceutical Design, Vol. 13, Núm. 11, pp. 1113-1139
-
Tuning immune tolerance with vasoactive intestinal peptide: A new therapeutic approach for immune disorders
Peptides, Vol. 28, Núm. 9, pp. 1833-1846